Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prostate cancer-associated SPOP mutations lead to genomic instability through disruption of the SPOP–HIPK2 axis
Xiaofeng Jin, Shi Qing, Qian Li, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 12, pp. 6788-6803
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Targeting PI3K/Akt signaling in prostate cancer therapy
Mehrdad Hashemi, Afshin Taheriazam, Padideh Daneii, et al.
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 3, pp. 423-443
Open Access | Times Cited: 49
Deregulation of SPOP in Cancer
Hui Zhang, Xiaofeng Jin, Haojie Huang
Cancer Research (2022) Vol. 83, Iss. 4, pp. 489-499
Open Access | Times Cited: 30
HIPK2 in cancer biology and therapy: Recent findings and future perspectives
A. Conte, Valeria Valente, Simona Paladino, et al.
Cellular Signalling (2022) Vol. 101, pp. 110491-110491
Open Access | Times Cited: 23
O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma
Peng Zhou, Wen‐Yi Chang, Deao Gong, et al.
Oncogene (2023) Vol. 42, Iss. 10, pp. 725-736
Closed Access | Times Cited: 15
Novel insights into the SPOP E3 ubiquitin ligase: From the regulation of molecular mechanisms to tumorigenesis
Xian-Miao Li, Huanlei Wu, Qi‐Dong Xia, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112882-112882
Open Access | Times Cited: 20
The functions and effects of CUL3-E3 ligases mediated non-degradative ubiquitination
Fengguang Zhai, Jingyun Li, Meng Ye, et al.
Gene (2022) Vol. 832, pp. 146562-146562
Closed Access | Times Cited: 17
In-silico structural and functional analysis of nonsynonymous single nucleotide polymorphisms in human FOLH1 gene
Abtin Tondar, Muhammad Irfan, Sergio Sánchez-Herrero, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access
SPOP mutations increase PARP inhibitor sensitivity via CK2/PIAS1/SPOP axis in prostate cancer
Hui Zhang, Lianbao Kong, Jinhui Li, et al.
JCI Insight (2025) Vol. 10, Iss. 8
Open Access
Rewired glycolysis by DTL accelerates oncometabolite L-lactate generation to promote breast cancer progression
Yuhao Liu, Jinting Li, Yiren Cao, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Pathology and treatment for prostate cancer: Based on prostate stem cells and cell therapy
Zhiwei He
Deleted Journal (2025), pp. 1-14
Closed Access
Targeting mRNA-coding genes in prostate cancer using CRISPR/Cas9 technology with a special focus on androgen receptor signaling
Mobina Tabibian, Fahimeh Salasar Moghaddam, Elahe Motevaseli, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
The E3 Ligases in Cervical Cancer and Endometrial Cancer
Fengguang Zhai, Jie Wang, Weili Yang, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5354-5354
Open Access | Times Cited: 13
ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression
Yizeng Fan, Tao Hou, Weichao Dan, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 8, pp. 1611-1624
Open Access | Times Cited: 11
Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer
Jie Zhou, Yiming Lai, Shengmeng Peng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
SPOP in Cancer: Phenomena, Mechanisms and Its Role in Therapeutic Implications
Xiaojuan Yang, Qing Zhu
Genes (2022) Vol. 13, Iss. 11, pp. 2051-2051
Open Access | Times Cited: 8
Effect of ubiquitin protease system on DNA damage response in prostate cancer (Review)
Lin Yan, Xiaofeng Jin
Experimental and Therapeutic Medicine (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 4
ASH2L-mediated H3K4me3 drives diabetic nephropathy through HIPK2 and Notch1 pathway
Wen Zhong, Hong Chen, Yuyu Zhang, et al.
Translational research (2023) Vol. 264, pp. 85-96
Closed Access | Times Cited: 4
SPOP promotes CREB5 ubiquitination to inhibit MET signaling in liver cancer
Deao Gong, Peng Zhou, Wen-yi Chang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1871, Iss. 2, pp. 119642-119642
Closed Access | Times Cited: 4
SPOP negatively regulates mTORC1 activity by ubiquitinating Sec13
Yong Yang, Yanchun Han, Qi Cao, et al.
Cellular Signalling (2024) Vol. 116, pp. 111060-111060
Closed Access | Times Cited: 1
CircHIPK2 promotes proliferation of nasopharyngeal carcinoma by down-regulating HIPK2
Dan Zhang, Haiping Huang, Yangguang Sun, et al.
Translational Cancer Research (2022) Vol. 11, Iss. 7, pp. 2348-2358
Open Access | Times Cited: 6
SPOP is essential for DNA replication licensing through maintaining translation of CDT1 and CDC6 in HaCaT cells
Sayoko Sanada, Masashi Maekawa, Sota Tate, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 651, pp. 30-38
Open Access | Times Cited: 3
Development and validation of a tumor immune cell infiltration-related gene signature for recurrence prediction by weighted gene co-expression network analysis in prostate cancer
Linying Xie, Hanying Huang, Yulei Hao, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2
HIPK2 attenuates bleomycin-induced pulmonary fibrosis by suppressing the Wnt/β-catenin signaling pathway
Fangfang Wang, Yanan Zhang, Jing Ren, et al.
Folia Histochemica et Cytobiologica (2022) Vol. 60, Iss. 3, pp. 247-259
Open Access | Times Cited: 3
SPOP inhibits BRAF-dependent tumorigenesis through promoting non-degradative ubiquitination of BRAF
Kai Feng, Qing Shi, Dongyue Jiao, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Clinicopathological and prognostic significance of speckle-type POZ protein in cancers: a systematic review and meta-analysis
Yan He, Jun Chen, Xingchen Peng, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top